PC
Paul Choi Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
32.1%
Neutral
46.4%
Negative
21.4%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Sell
Maintained
| $50 |
35%
downside
| 1 | -14% |
0
%
| 5 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $100 |
36%
upside
| 1 | +16% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $55 |
32%
upside
| 1 | +5.7% |
0
%
| 29 Oct ‘25 1 month ago |
|
|
|
Sell
Downgraded
| $6 |
53%
downside
| 3 | -36% |
0
%
| 15 Oct ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| $77 |
22%
upside
| 2 | -44% |
0
%
| 8 Oct ‘25 1 month ago |
|
|
|
Neutral
Initiated
| $20 |
15%
downside
| 1 | – |
–
| 25 Sep ‘25 2 months ago |
|
|
|
Buy
Initiated
| $47 |
6%
upside
| 1 | +13% |
0
%
| 17 Sep ‘25 2 months ago |
|
|
|
Sell
Maintained
| $12 |
27%
downside
| 2 | -37% |
0
%
| 25 Jun ‘25 5 months ago |
|
|
|
Neutral
Maintained
| $3 |
87%
downside
| 2 | – |
–
| 22 May ‘25 6 months ago |
|
|
|
Buy
Maintained
| $8 |
140%
upside
| 2 | +122% |
0
%
| 16 May ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $5 |
66%
downside
| 3 | – |
–
| 2 May ‘25 7 months ago |
|
|
|
Buy
Maintained
| $52 |
16%
upside
| 1 | +33% |
0
%
| 17 Apr ‘25 7 months ago |
|
|
|
Buy
Maintained
| $21 |
223%
upside
| 1 | +19% |
0
%
| 17 Apr ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $12 |
9%
downside
| 2 | – |
–
| 17 Apr ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $3 |
20%
downside
| 2 | – |
–
| 17 Apr ‘25 7 months ago |
|
|
|
Sell
Maintained
| $10 |
8%
downside
| 2 | +8.5% |
0
%
| 17 Apr ‘25 7 months ago |
|
|
|
Buy
Maintained
| $225 |
10%
upside
| 1 | +63% |
0
%
| 13 Feb ‘25 9 months ago |
|